Category Lobbying

MSF: AstraZeneca Pullout Of Neglected Disease R&D Proof System Broken

Following news reports that pharmaceutical producer AstraZeneca will end its spending on early stage research and development for tuberculosis, malaria and neglected tropical diseases, Médecins Sans Frontières issued a statement saying the move is further proof that substantive change to the global pharmaceutical R&D system is needed.

New Study Makes Case for Innovative Medicines

A new pharmaceutical industry-backed study draws attention to the value of innovative medicines in reducing healthcare costs and to the wider society that goes beyond clinical and personal values. However, in middle income countries, national prioritisation and improvements in healthcare infrastructure are needed to maximise the value of medicinal innovation, the study found.

WHO Chief: No Government Should Be Intimidated For Doing “Right Thing” In Public Health

Discussions on access to essential medicines yesterday at the World Health Organization were in some ways overshadowed by the recent leak of a global pharmaceutical campaign aimed at derailing efforts by the South African government to revise its intellectual property policy. WHO Director General Margaret Chan strongly supported South Africa, as did several developing countries, while developed countries remained silent on the subject.

WHO Board Tackles Reform, Engagement With Non-State Actors

The World Health Organization Executive Board spent long hours this week discussing the progress of the reform of the organisation. Among items covered were the reform implementation plan, the engagement of WHO with non-state actors, and ways to improve decision-making by the organisation’s governing bodies.

Top IP-Watch Stories Of 2013: India, Marrakesh Treaty, Seed/Gene Patents, WIPO Election

Looking back on 2013, the list of the most-viewed stories on the Intellectual Property Watch website shows that reporting on activities in India, especially related to patents and public health, continued to draw the most attention. Other top stories were the Marrakesh Treaty on copyright exceptions for blind readers, legal cases involving patents on seeds and on plant and human genes, the election for World Intellectual Property Organization director general, free-trade agreements (including the Wikileaks leak of the IP chapter of the Trans-Atlantic Partnership agreement), Russian copyrights, and 3D printing.

Academics, Authors Worldwide Start 2014 Strongly Against Surveillance

More than 250 academics from around the world have signed a declaration strongly calling for a stop to surveillance of citizens' communications online by US and European authorities. And in December, more than 500 top authors joined a coalition called Writers against Mass Surveillance calling for international rules to curb wholesale surveillance.